EN HU

Hársfalvi Jolán

Hársfalvi Jolán
Name: Hársfalvi Jolán
Other profiles: MTMT

Publication list

Uploaded publications:
119
Publications in DEA:
113
OA:
12
Date range:
1976-2022
2022
1.
Radnay, Z., Illés, Á., Udvardy, M., Prohászka, Z., Sinkovits, G., Csányi, M. C., Kellermayer, M., Kiss, A., Hársfalvi, J.: Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation.
Transplantation and Cellular Therapy. 28 (12), 830, 2022.
2020
2.
Hársfalvi, J., Molnár, Z., Csányi, M. C., Domján, I., Flaskó, T., Kaposi, A., Benyó, M.: Long-lasting prothrombotic state implied by changes of plasma von Willebrand factor parameters after radical prostatectomy for prostate malignancy.
Urol. Oncol.-Semin. Orig. Investig. 38 (4), 191-197, 2020.
Journal metrics:
Q2 Oncology
Q1 Urology
2018
3.
Pályu, E., Hársfalvi, J., Tornai, T. I., Papp, M., Udvardy, M., Szekeres-Csiki, K., Pataki, L., Vanhoorelbeke, K., Feys, H. B., Deckmyn, H., Tornai, I.: Major changes of von Willebrand factor multimer distribution in cirrhotic patients with stable disease or acute decompensation.
Thromb. Haemost. 118 (8), 1397-1408, 2018.
Journal metrics:
Q1 Hematology
2017
4.
Rentka, A., Nagy, A., Hársfalvi, J., Szűcs, G., Szekanecz, Z., Gesztelyi, R., Szodoray, P., Kemény-Beke, Á.: Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis.
Rheumatol. Int. 37 (11), 1835-1845, 2017.
Journal metrics:
Q3 Immunology
Q2 Immunology and Allergy
Q2 Rheumatology
5.
Rentka, A., Köröskényi, K., Hársfalvi, J., Szekanecz, Z., Szűcs, G., Szodoray, P., Kemény-Beke, Á.: Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis.
Ann. Clin. Biochem. 54 (5), 521-529, 2017.
Journal metrics:
Q3 Clinical Biochemistry
Q2 Medicine (miscellaneous)
6.
Rentka, A., Köröskényi, K., Hársfalvi, J., Szekanecz, Z., Szűcs, G., Szodoray, P., Kemény-Beke, Á.: Ohpthalmological manifestations and tear investigations in systemic sclerosis.
In: Systemic sclerosis / Mislav Radic, IntechOpen, London, 137-155, 2017. ISBN: 9789535150459
2016
7.
Radnay, Z., Udvardy, M., Papp, M., Hársfalvi, J., Rejtő, L., Pál, I., Illés, Á., Kiss, A.: Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation.
Transplant. Proc. 48, 3397-3405, 2016.
Journal metrics:
Q2 Surgery
Q3 Transplantation
8.
Káplár, M., Sweni, S., Kulcsár, J., Cogoi, B., Esze, R., Somodi, S., Papp, M., Oláh, L., Magyar, M. T., Szabó, K. J., Czuriga-Kovács, K. R., Hársfalvi, J., Paragh, G.: Mannose-binding lectin levels and carotid intima-media thickness in type 2 diabetic patients.
J. Diabetes Res. 2016 (8132925), 1-8, 2016.
Journal metrics:
Q2 Endocrinology
Q2 Endocrinology, Diabetes and Metabolism
9.
Rentka, A., Hársfalvi, J., Szűcs, G., Szekanecz, Z., Szodoray, P., Köröskényi, K., Kemény-Beke, Á.: Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis.
Immunol. Res. 64 (2), 619-626, 2016.
Journal metrics:
Q2 Immunology
2015
10.
Kulcsár, J., Cogoi, B., Karányi, Z., Szabó, K. J., Czuriga-Kovács, K. R., Oláh, L., Hársfalvi, J., Paragh, G., Káplár, M.: Haptoglobin (2-2) Polymorphism together with elevated homocystein level enhance the risk for subclinical atherosclerosis in type 2 diabetic men.
Atherosclerosis. 241 (1), e179-e180, 2015.
11.
Sipeki, N., Dávida, L., Pályu, E., Altorjay, I., Hársfalvi, J., Antal-Szalmás, P., Szabó, Z., Veres, G., Shums, Z., Norman, G. L., Lakatos, P., Papp, M.: Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
World J. Gastroenterol. 21 (22), 6952-6964, 2015.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
12.
Cogoi, B., Kulcsár, J., Karányi, Z., Szabó, K. J., Czuriga-Kovács, K. R., Oláh, L., Hársfalvi, J., Paragh, G., Káplár, M.: The effect of haptoglobin polymorphism and rosiglitazone treatment on the carotid artery intima-media thickness in type 2 diabetic patients: a 7-year follow-up.
Atherosclerosis. 241 (1), e179, 2015.
13.
Selmeczi, A., Roach, R. E. J., Móré, C., Batta, Z., Hársfalvi, J., Van de Bom, A., Boda, Z., Oláh, Z.: Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
Thromb. Haemost. 113 (2), 283-289, 2015.
Journal metrics:
Q1 Hematology
14.
Rentka, A., Hársfalvi, J., Berta, A., Köröskényi, K., Szekanecz, Z., Szűcs, G., Szodoray, P., Kemény-Beke, Á.: Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis.
Mediat. Inflamm. 2015, 1-4, 2015.
Journal metrics:
Q2 Cell Biology
Q2 Immunology
2014
15.
Benyó, M., Hársfalvi, J., Pfliegler, G., Molnár, Z., Murányi, M., Józsa, T., Flaskó, T.: Present practice of thrombosis prophylaxis of radical prostatectomy in a European country - a Hungarian multicenter study.
Urol. Int. 92 (3), 289-293, 2014.
Journal metrics:
Q2 Urology
16.
Benyó, M., Hársfalvi, J., Pfliegler, G., Kiss, Z., Murányi, M., Berczi, C., Varga, A., Flaskó, T.: Trombózis profilaxis gyakorlat a magyar urológiai osztályokon.
Magyar Urol. 26 (1), 2014.
2013
17.
Szalóki, M., Vitályos, G., Hársfalvi, J., Hegedűs, C.: Binding of leachable components of polymethyl methacrylate (PMMA) and peptide on modified SPR chip.
IOP Conf. Ser. Mater. Sci. Eng. 47, 1-6, 2013.
18.
Mitchell, J. A., Nagymihály, R., Uhrinyi, Ö. M., Hársfalvi, J.: Measurement of Thrombin in Different Matrices: whole Blood, Platelet-Rich and Platelet-Poor Plasma Using Fluorogenic Substrate ZGGR-AMC.
Acta Haematol. 130 (3), 150-152, 2013.
Journal metrics:
Q3 Hematology
Q2 Medicine (miscellaneous)
2012
19.
Papp, M., Vitális, Z., Altorjay, I., Tornai, I., Udvardy, M., Hársfalvi, J., Vida, A., Kappelmayer, J., Lakatos, P., Antal-Szalmás, P.: Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.
Liver Int. 32 (4), 603-611, 2012.
Journal metrics:
Q1 Hepatology
20.
Vitályos, G., Szalóki, M., Hársfalvi, J., Hegedűs, C.: Binding of oligopeptide to polymethyl methacrylate surface.
J. Dent. Res. 91 (B), 3210, 2012.
21.
Mendelboum Raviv, S., Szekeres-Csiki, K., Jenei, A., Nagy, J., Shenkman, B., Savion, N., Hársfalvi, J.: Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding.
Thromb. Res. 129 (4), e29-e35, 2012.
Journal metrics:
Q2 Hematology
22.
Daragó, A., Fagyas, M., Mányiné Siket, I., Facskó, A., Megyesi, Z., Kalász, J., Galajda, Z., Szerafin, T., Hársfalvi, J., Édes, I., Papp, Z., Tóth, A., Szentmiklósi, J. A.: Differences in Angiotensin Convertase Enzyme (ACE) Activity and Expression May Contribute to Shorter Event Free Period After Coronary Artery Bypass Graft Surgery.
Cardiovasc. Ther. 30 (3), 136-144, 2012.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q1 Medicine (miscellaneous)
Q2 Pharmacology
Q1 Pharmacology (medical)
23.
Bagoly, Z., Koncz, Z., Hársfalvi, J., Muszbek, L.: Factor XIII, clot structure, thrombosis.
Thromb. Res. 129 (3), 382-387, 2012.
Journal metrics:
Q2 Hematology
24.
Benyó, M., Flaskó, T., Molnár, Z., Kerényi, A., Batta, Z., Józsa, T., Hársfalvi, J.: Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased Hypercoagulability.
PLoS One. 7 (12), e51299, 2012.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2011
25.
Radnay, Z., Udvardy, M., Kiss, A., Papp, M., Rejtő, L., Hársfalvi, J., Masszi, T., Szász, R., Batár, P., Reményi, G., Telek, B.: A New Approach to Predict the Chance of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation: Mannose-Binding Lectin ELISA.
Blood. 118 (21), 4492, 2011.
DEENK University of Debrecen
© 2012 University of Debrecen